Press release
Hereditary Angioedema Therapeutics Market 2023 | Key Drivers, Size, Trends And Outlook By 2032
Hereditary Angioedema Therapeutics Market Analysis
The Business Research Company's Hereditary Angioedema Therapeutics Global Market Report 2023 identifies rising prevalence of hereditary angioedema as the major driver for the hereditary angioedema therapeutics market's growth in the forecast period. Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of severe swelling of the skin and mucous membranes. The swelling is caused by excess fluid build-up (EDEMA) and can occur anywhere in the body, including the hands and feet, face, intestines, and airways.
The global hereditary angioedema therapeutics market size is expected to grow from $4.88 billion in 2022 to $5.74 billion in 2023 at a compound annual growth rate (CAGR) of 17.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global hereditary angioedema therapeutics market size is expected to reach $11.29 billion in 2027 at a CAGR of 18.3%.
Download Free Sample Of Hereditary Angioedema Therapeutics Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=10810&type=smp
Major competitors in the hereditary angioedema therapeutics market are Shire plc, Sanofi, Pharming Healthcare Inc., Attune Pharmaceuticals, Adverum Biotechnologies, Arrowhead Pharmaceuticals.
A key trend in the hereditary angioedema therapeutics market includes product innovations. Major players are adopting advanced technologies to strengthen their poMajor companies operating in the hereditary angioedema therapeutics market are developing innovative products such as ligand-conjugated (LICA) investigational antisense medicine and gene therapy to sustain their position in the market. For Instance, in March 2023, Intellia Therapeutics, a US-based clinical-stage biotechnology company, launched an Investigational New Drug (IND) NTLA-2002, which was approved by the United States Food and Drug Administration for the treatment of hereditary angioedema. This enables the company's ongoing Phase 1/2 trial to include the US in the worldwide Phase 2 part. After a single dose of therapy, the inactivation of the target gene, kallikrein B1 (KLKB1), will permanently lower plasma kallikrein protein activity and prevent HAE attacks. NTLA-2002 is a candidate for in vivo genome editing.
Read More On The Global Hereditary Angioedema Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/hereditary-angioedema-therapeutics-global-market-report
The hereditary angioedema therapeutics market is segmented -
1) By Drug Class: C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes
2) By Route of Administration: Intravenous, Subcutaneous, Oral
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
4) By Application: Prophylaxis, On-demand
• By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the hereditary angioedema therapeutics market.
The Business Research Company's "Global Hereditary Angioedema Therapeutics Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Hereditary Angioedema Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10810
The Table Of Content For The Hereditary Angioedema Therapeutics Market Include:
1. Executive Summary
2. Hereditary Angioedema Therapeutics Market Characteristics
3. Hereditary Angioedema Therapeutics Market Trends And Strategies
4. Hereditary Angioedema Therapeutics Market - Macro Economic Scenario
5. Hereditary Angioedema Therapeutics Market Size And Growth
….
26. Africa Hereditary Angioedema Therapeutics Market
27. Hereditary Angioedema Therapeutics Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Hereditary Angioedema Therapeutics Market
29. Hereditary Angioedema Therapeutics Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hereditary Angioedema Therapeutics Market 2023 | Key Drivers, Size, Trends And Outlook By 2032 here
News-ID: 3165976 • Views: …
More Releases from The Business research company
Analysis of Key Market Segments Driving the Prismatic Cell Assembly Automation M …
The prismatic cell assembly automation market is on track for remarkable expansion in the coming years, driven by rapid technological advancements and increasing demand across various sectors. As industries seek higher efficiency and automation in battery production, this market is gaining significant traction. Let's explore the market's size, key players, emerging trends, and the segments shaping its growth.
Projected Market Size and Growth Trajectory for Prismatic Cell Assembly Automation
The prismatic cell…
Market Trend Insights: The Impact of Recent Advances on the Plasma Pyrolysis Hyd …
The plasma pyrolysis hydrogen market is positioned for remarkable expansion in the coming years, driven by growing environmental consciousness and technological innovations. This emerging sector offers promising solutions to meet the increasing demand for clean energy by utilizing advanced plasma pyrolysis methods. Let's explore the current market size, key players, influential trends, and segmentation to understand the dynamics shaping this industry.
Projected Growth and Size of the Plasma Pyrolysis Hydrogen Market
The…
Trends in Growth, Market Segmentation, and Competitive Approaches Influencing th …
The patient data hub solutions sector is set to experience remarkable expansion in the coming years, driven by technological advancements and evolving healthcare needs. This market plays a crucial role in improving patient care by enabling better data management and analytics. Let's explore its current market value, key players, emerging trends, and the various segments defining this growing industry.
Expected Market Size and Growth Trajectory of the Patient Data Hub Solutions…
Analysis of Key Market Segments Influencing the Optical Transport Network (OTN) …
The optical transport network (OTN) hardware sector is positioned for significant growth as demand for faster and more efficient data transmission continues to rise. With rapid technological advancements and increasing integration of next-generation networks, the market is becoming a critical pillar for supporting digital infrastructure worldwide. Let's explore the current market size, key players, influential trends, and industry segments shaping the future of OTN hardware.
Projected Market Value and Growth Drivers…
More Releases for Hereditary
Unraveling Hereditary Cancer With The Rising Demand For Hereditary Cancer Testin …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Hereditary Cancer Testing Industry Market Size Be by 2025?
The market encompassing hereditary cancer testing has exhibited robust expansion throughout the recent past, projecting an increase from its value of $4.32 billion in 2024 to reach $4.75 billion for the subsequent year, reflecting a consistent annual…
Leber Hereditary Optic Neuropathy Treatment Market
Introduction
Leber Hereditary Optic Neuropathy (LHON) is a genetic condition that leads to severe vision loss, primarily affecting young adults. This disorder is caused by mutations in mitochondrial DNA, which impairs the function of retinal ganglion cells. As awareness of LHON has grown, so too has the focus on its treatment options. The LHON treatment market is evolving rapidly, driven by advancements in genetic therapies, pharmaceuticals, and supportive care strategies. This…
Hereditary Hemochromatosis Market - Redefining Care, Inspiring Hope: Hereditary …
Newark, New Castle, USA: The "Hereditary Hemochromatosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Hereditary Hemochromatosis Market: https://www.growthplusreports.com/report/hereditary-hemochromatosis-market/8793
This latest report researches the industry structure, sales, revenue,…
Hereditary Angioedema Market Research Report 2032
DelveInsight's "Hereditary Angioedema Market Insights, Epidemiology, and Market Forecast 2032" report delivers an in-depth understanding of the Hereditary Angioedema, historical and forecasted epidemiology as well as the Hereditary Angioedema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Hereditary Angioedema (HAE) is a rare genetic disorder caused by the deficiency in functional C1 inhibitor (C1INH) that results in recurrent attacks of localized subcutaneous or…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Global Hereditary Angioedema Market report from Global Insight Services is the single authoritative source of intelligence on hereditary angioedema market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types,…
Hereditary Angioedema - Drug Pipeline Landscape, 2022
Hereditary Angioedema is an infrequent inherited disease that causes substantial swelling in various body tissues, such as the abdomen or face caused by a low level or improper function of a protein called the C1 inhibitor. There are three types of hereditary angioedema namely type I, II, and III.
Hereditary Angioedema is mainly caused by a low level or improper function of a protein called the C1 inhibitor.
Read more about Hereditary…
